Baird Medical Advances Physician Training In Microwave Ablation For Thyroid Treatment

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted its recent series of sponsored physician training programs hosted at premier U.S. academic medical centers. Over the past several months, these intensive, hands-on courses at Tulane University and Columbia University have advanced the clinical proficiency of physicians in the use of MWA for thyroid nodule treatment.

These initiatives underscore Baird Medical's commitment to fostering clinical excellence and ensuring the safe, effective adoption of its MWA technology. In May, a session at Tulane University led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery, provided immersive training through five live cases for specialists from The George Washington University, UT Health Houston, and Texas Tech University Health Sciences Center. Concurrently, Baird Medical sponsored two specialized courses at Columbia University in May and August, where Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program, trained physicians from UCSF Health and Dignity Health. These sessions demonstrated the profound clinical impact and efficiency of Baird's system, highlighted by the successful ablation of large thyroid nodules.